Company Filing History:
Years Active: 2023
Title: Innovative Contributions of June Sung: Advancements in Mitochondrial Detection
Introduction: June Sung, a prominent inventor based in Siheung-si, South Korea, has made significant strides in the field of fluorescent probe technology. With a focus on mitochondrial detection and cancer diagnosis, Sung's innovative work has furthered the understanding and capabilities of near-infrared fluorescent probes.
Latest Patents: June Sung holds a valuable patent titled "Silicon-rhodamine fluorescent probe containing hydrophobic group and use thereof." This invention introduces a novel near-infrared fluorescent probe that exhibits specificity for mitochondria, driven by the incorporation of a hydrophobic group attached to a silicon-rhodamine core. Unlike conventional probes, this innovative fluorescent probe boasts improved mitochondrial targeting efficiency, allowing for high sensitivity and specificity in detecting mitochondria in living tissues within the near-infrared (NIR) region, ranging from 700 to 1,700 nm. This advancement facilitates the acquisition of three-dimensional high-resolution biological images without causing harm to the human body, making it an essential tool for mitochondrial detection in research laboratories, as well as a promising contrast agent or drug delivery carrier in cancer diagnosis and surgical procedures.
Career Highlights: June Sung is affiliated with Ajou University Industry-Academic Corporation Foundation, where he leverages his expertise to advance research and innovation. His focus on medical technology and the development of fluorescent probes is pivotal in pushing the boundaries of what is possible in biomedicine.
Collaborations: Throughout his career, Sung has collaborated with esteemed colleagues such as EunHa Kim and Wook Hwan Kim. These collaborations play a fundamental role in enhancing the effectiveness and application of his research within clinical and laboratory settings.
Conclusion: June Sung's contributions to the field of fluorescent probe technology demonstrate his dedication to innovation and advancing medical diagnostics. His patent for a silicon-rhodamine fluorescent probe signifies a leap forward in mitochondrial detection, with potential applications in cancer diagnosis and treatment. Overall, Sung's work exemplifies the critical intersection of science, technology, and healthcare, promising to improve patient outcomes and enhance research methodologies in the years to come.